Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 3 |
2021 | 3 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
A Dual Anti-Inflammatory and Anti-Proliferative 3-Styrylchromone Derivative Synergistically Enhances the Anti-Cancer Effects of DNA-Damaging Agents on Colon Cancer Cells by Targeting HMGB1-RAGE-ERK1/2 Signaling.
Int J Mol Sci. 2022 Mar 22;23(7):3426. doi: 10.3390/ijms23073426.
Int J Mol Sci. 2022.
PMID: 35408786
Free PMC article.
Trimebutine suppresses Toll-like receptor 2/4/7/8/9 signaling pathways in macrophages.
Ogawa N, Nakajima S, Tamada K, Yokoue N, Tachibana H, Okazawa M, Oyama T, Abe H, Yamazaki H, Yoshimori A, Sato A, Kamiya T, Yokomizo T, Uchiumi F, Abe T, Tanuma SI.
Ogawa N, et al. Among authors: okazawa m.
Arch Biochem Biophys. 2021 Oct 30;711:109029. doi: 10.1016/j.abb.2021.109029. Epub 2021 Sep 10.
Arch Biochem Biophys. 2021.
PMID: 34517011
Item in Clipboard
A 3-styrylchromone converted from trimebutine 3D pharmacophore possesses dual suppressive effects on RAGE and TLR4 signaling pathways.
Okazawa M, Oyama T, Abe H, Yamazaki H, Yoshimori A, Tsukimoto M, Yoshizawa K, Takao K, Sugita Y, Kamiya T, Uchiumi F, Sakagami H, Abe T, Tanuma SI.
Okazawa M, et al.
Biochem Biophys Res Commun. 2021 Aug 20;566:1-8. doi: 10.1016/j.bbrc.2021.05.096. Epub 2021 Jun 7.
Biochem Biophys Res Commun. 2021.
PMID: 34111666
Item in Clipboard
A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling.
Abe H, Okazawa M, Oyama T, Yamazaki H, Yoshimori A, Kamiya T, Tsukimoto M, Takao K, Sugita Y, Sakagami H, Abe T, Tanuma SI.
Abe H, et al. Among authors: okazawa m.
Medicines (Basel). 2021 Mar 24;8(4):17. doi: 10.3390/medicines8040017.
Medicines (Basel). 2021.
PMID: 33805209
Free PMC article.
Item in Clipboard
Trimebutine attenuates high mobility group box 1-receptor for advanced glycation end-products inflammatory signaling pathways.
Nakajima S, Ogawa N, Yokoue N, Tachibana H, Tamada K, Okazawa M, Sato A, Oyama T, Abe H, Kamiya T, Yoshimori A, Yoshizawa K, Inoue S, Yokomizo T, Uchiumi F, Abe T, Tanuma SI.
Nakajima S, et al. Among authors: okazawa m.
Biochem Biophys Res Commun. 2020 Dec 17;533(4):1155-1161. doi: 10.1016/j.bbrc.2020.09.126. Epub 2020 Oct 8.
Biochem Biophys Res Commun. 2020.
PMID: 33041002
Item in Clipboard
Structural Basis of Beneficial Design for Effective Nicotinamide Phosphoribosyltransferase Inhibitors.
Tanuma SI, Katsuragi K, Oyama T, Yoshimori A, Shibasaki Y, Asawa Y, Yamazaki H, Makino K, Okazawa M, Ogino Y, Sakamoto Y, Nomura M, Sato A, Abe H, Nakamura H, Takahashi H, Tanuma N, Uchiumi F.
Tanuma SI, et al. Among authors: okazawa m.
Molecules. 2020 Aug 10;25(16):3633. doi: 10.3390/molecules25163633.
Molecules. 2020.
PMID: 32785052
Free PMC article.
Item in Clipboard
Structural insights into the active site of poly(ADP-ribose) glycohydrolase using docking modes of 6-hydroxy-3H-xanthen-3-one derivative inhibitors.
Shibui Y, Oyama T, Okazawa M, Yoshimori A, Abe H, Uchiumi F, Tanuma SI.
Shibui Y, et al. Among authors: okazawa m.
Bioorg Med Chem. 2020 Feb 1;28(3):115249. doi: 10.1016/j.bmc.2019.115249. Epub 2019 Dec 6.
Bioorg Med Chem. 2020.
PMID: 31879180
Item in Clipboard
Cite
Cite